192 related articles for article (PubMed ID: 28423498)
1. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
[TBL] [Abstract][Full Text] [Related]
3. Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.
Chanda A; Chan A; Deng L; Kornaga EN; Enwere EK; Morris DG; Bonni S
PLoS One; 2017; 12(5):e0177639. PubMed ID: 28493978
[TBL] [Abstract][Full Text] [Related]
4. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
[TBL] [Abstract][Full Text] [Related]
5. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.
Spoden GA; Morandell D; Ehehalt D; Fiedler M; Jansen-Dürr P; Hermann M; Zwerschke W
J Cell Biochem; 2009 May; 107(2):293-302. PubMed ID: 19308990
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide destabilizes Pias3 and regulates sumoylation.
Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
David D; Surendran A; Thulaseedharan JV; Nair AS
BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
[TBL] [Abstract][Full Text] [Related]
8. Neuronal activity-induced SUMOylation of Akt1 by PIAS3 is required for long-term potentiation of synaptic transmission.
Meng L; Du CP; Lu CY; Zhang K; Li L; Yan JZ; Hou XY
FASEB J; 2021 Aug; 35(8):e21769. PubMed ID: 34288124
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation of the GTPase Rac1 is required for optimal cell migration.
Castillo-Lluva S; Tatham MH; Jones RC; Jaffray EG; Edmondson RD; Hay RT; Malliri A
Nat Cell Biol; 2010 Nov; 12(11):1078-85. PubMed ID: 20935639
[TBL] [Abstract][Full Text] [Related]
10. Differential PIAS3 expression in human malignancy.
Wang L; Banerjee S
Oncol Rep; 2004 Jun; 11(6):1319-24. PubMed ID: 15138572
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
12. Activity-Induced SUMOylation of Neuronal Nitric Oxide Synthase Is Associated with Plasticity of Synaptic Transmission and Extracellular Signal-Regulated Kinase 1/2 Signaling.
Du CP; Wang M; Geng C; Hu B; Meng L; Xu Y; Cheng B; Wang N; Zhu QJ; Hou XY
Antioxid Redox Signal; 2020 Jan; 32(1):18-34. PubMed ID: 31642335
[No Abstract] [Full Text] [Related]
13. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.
Rubio MD; Wood K; Haroutunian V; Meador-Woodruff JH
Neuropsychopharmacology; 2013 Sep; 38(10):1910-20. PubMed ID: 23571678
[TBL] [Abstract][Full Text] [Related]
15. NF-κB repression by PIAS3 mediated RelA SUMOylation.
Liu Y; Bridges R; Wortham A; Kulesz-Martin M
PLoS One; 2012; 7(5):e37636. PubMed ID: 22649547
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
17. Disrupting PIAS3-mediated SUMOylation of MLK3 ameliorates poststroke neuronal damage and deficits in cognitive and sensorimotor behaviors.
Jiang Y; Hu L; Wang B; Zhang B; Shao M; Meng L; Xu Y; Chen R; Li M; Du C
Cell Mol Life Sci; 2024 Mar; 81(1):119. PubMed ID: 38456949
[TBL] [Abstract][Full Text] [Related]
18. Trophic factor BDNF inhibits GABAergic signaling by facilitating dendritic enrichment of SUMO E3 ligase PIAS3 and altering gephyrin scaffold.
Thirouin ZS; Figueiredo M; Hleihil M; Gill R; Bosshard G; McKinney RA; Tyagarajan SK
J Biol Chem; 2022 May; 298(5):101840. PubMed ID: 35307349
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.
Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME
Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration.
Wang L; Zhang J; Banerjee S; Barnes L; Sajja V; Liu Y; Guo B; Du Y; Agarwal MK; Wald DN; Wang Q; Yang J
Oncotarget; 2010 Nov; 1(7):620-627. PubMed ID: 21317457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
